Related Experiment Video
Updated: Jan 22, 2026

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes
Published on: March 2, 2020
Acute Bacterial Meningitis: Challenges to Better Antibiotic Therapy
Colin Kietzman1, Elaine Tuomanen1
1Department of Infectious Diseases , St. Jude Children's Research Hospital , 262 Danny Thomas Place , Memphis , Tennessee 38105 , United States.
Abstract:
Bacterial meningitis is a medical emergency requiring highly bactericidal antibiotics to achieve cure. Many challenges exist to achieving optimal patient outcome. First, antibiotics must pass the blood brain barrier. Once in the subarachnoid space, achieving bactericidal therapy involves circumventing antibiotic resistance and, more commonly, antibiotic tolerance arising from the slow growth of bacteria in the nutrient poor cerebrospinal fluid. Finally, bactericidal therapy is most often bacteriolytic, and debris from lysis is highly inflammatory. Controlling damage from lytic products may require adjunctive therapy to prevent neuronal death. These challenges are an extreme example of the different requirements for treating infections in different body sites.
Insights
Treating bacterial meningitis requires antibiotics that penetrate the blood-brain barrier and overcome bacterial resistance or tolerance. Lytic debris also necessitates managing inflammation to prevent neuronal damage.
Area of Science:
- Infectious Diseases
- Neuroscience
- Pharmacology
Background:
- Bacterial meningitis is a critical medical emergency demanding effective antibiotic treatment.
- Optimal patient outcomes are hindered by several challenges in treating this condition.
Purpose of the Study:
- To outline the multifaceted challenges in achieving successful therapeutic outcomes for bacterial meningitis.
- To highlight the unique pharmacokinetic and pharmacodynamic considerations for antibiotic treatment in the central nervous system.
Main Methods:
- Review of existing literature on bacterial meningitis treatment.
- Analysis of antibiotic penetration across the blood-brain barrier.
- Examination of bacterial resistance and tolerance mechanisms in cerebrospinal fluid.
- Evaluation of inflammatory responses to antibiotic-induced bacterial lysis.
Main Results:
- Antibiotics must effectively cross the blood-brain barrier to reach therapeutic concentrations.
- Bacterial tolerance, due to slow growth in cerebrospinal fluid, complicates eradication.
- Bacterial lysis releases inflammatory debris, potentially causing neuronal damage.
Conclusions:
- Bacterial meningitis treatment necessitates overcoming challenges related to drug delivery, antimicrobial resistance/tolerance, and inflammation.
- Adjunctive therapies may be required to mitigate damage from inflammatory byproducts of bacteriolytic treatments.
- These challenges exemplify the site-specific complexities in antimicrobial therapy.
Related Concept Videos
Antibiotic Selection
Cranial and Spinal Meninges
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
Bacterial Transformation
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Development of Antibiotic Resistance
Gene Therapy
Bacterial Signaling

